James Howard Tonsgard to Drug Evaluation, Preclinical
This is a "connection" page, showing publications James Howard Tonsgard has written about Drug Evaluation, Preclinical.
Connection Strength
0.019
-
Consensus recommendations to accelerate clinical trials for neurofibromatosis type 2. Clin Cancer Res. 2009 Aug 15; 15(16):5032-5039.
Score: 0.019